Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals
Happy New Year! We hope you had a restful holiday; If you took a break from keeping up with biotech news, we’ve got you covered with a brief rundown of the most important updates from the past week and a half. Pfizer won’t move forward with asking …